Aura Biosciences, Inc. AURA
Regular-session close
After hours · Nov 19, 4:01 PM ET
- YTD
- +28.07%
- 1 year
- +29.26%
Held by funds
72 US ETFs and mutual funds hold AURA · largest positions
- VTI 0.00% of fund $13.54M
- IWM 0.01% of fund $10.62M
- NJM 0.01% of fund $7.06M
- XBI 0.07% of fund $6.93M
- VXF 0.01% of fund $6.61M
- IBB 0.03% of fund $3.75M
- IWO 0.03% of fund $3.65M
- FSSNX 0.01% of fund $3.54M
- FSMAX 0.01% of fund $2.80M
- FESM 0.04% of fund $2.49M
- DFAS 0.01% of fund $2.37M
- VTWO 0.01% of fund $2.09M
- NAJ 0.01% of fund $1.85M
- VHT 0.01% of fund $1.56M
- ITOT 0.00% of fund $1.33M
- IWC 0.11% of fund $1.28M
- VEXRX 0.01% of fund $1.17M
- FSKAX 0.00% of fund $1.15M
- IJE 0.06% of fund $794.34K
- NLO 0.01% of fund $794.20K
Ownership
- Institutions 77.5%
- Insiders 5.08%
- Public and other holders 17.4%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Matrix Capital Management | 13.86% | 6,922,870 | 56.98M | Sep 29, 2024 |
| Eventide Asset Management LLC | 11.62% | 5,802,682 | 47.76M | Sep 29, 2024 |
| Adage Capital Partners GP L.L.C. | 9.77% | 4,881,125 | 40.17M | Sep 29, 2024 |
| Blackrock Inc. | 6.33% | 3,160,414 | 26.01M | Sep 29, 2024 |
| Medicxi Ventures Management (Jersey) Ltd | 6.09% | 3,039,892 | 25.02M | Sep 29, 2024 |
| Vanguard Group Inc | 3.61% | 1,805,434 | 14.86M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund | 11.62% | 5,802,682 | 47.76M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.27% | 1,133,224 | 9.33M | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 1.70% | 848,999 | 6.99M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.27% | 633,967 | 5.22M | Sep 29, 2024 |
| Franklin Strategic Series-Franklin Biotechnology Discove | 1.14% | 568,471 | 4.68M | Jul 30, 2024 |
| Fidelity Small Cap Index Fund | 0.95% | 473,964 | 3.90M | Aug 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs AURA, and what each was last paid
Natalie C. Holles, President, CEO & DirectorAverage age 55
| Name | Title | Pay | Age |
|---|---|---|---|
| Natalie C. Holles | President, CEO & Director | — | 53 |
| Jill Hopkins | Chief Medical Officer & President of Research and Development | $793K | 61 |
| Susan Abu-Absi | Chief Operating Officer | $593K | — |
| Amy Elazzouzi | Senior Vice President of Finance, Treasurer and Secretary | — | 52 |
| Erica Kratz | Chief Regulatory & Quality Officer | — | — |
| Julie Person | Chief People Officer | — | 52 |
| Patrick Nealon | Senior Vice President of Clinical Development Operations | — | — |
| Alex Dasalla | Head of Investor Relations & Corporate Communications | — | — |
| Anthony Daniels | Vice President & Therapeutic Area of Head Ocular Oncology | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DE LOS PINOS ELISABET | Chief Executive Officer | Sale | Oct 28, 2024 | 452,059 |
| ELAZZOUZI AMY | Officer | Sale | Oct 28, 2024 | 39,443 |
| FEDER JULIE B | Chief Financial Officer | Sale | Oct 17, 2024 | 134,276 |
| HOPKINS JANET JILL | Officer | Sale | Nov 17, 2024 | 151,693 |
| JOHNSON DAVID MICHAEL | Director | Stock Award(Grant) | Jun 19, 2024 | 435,839 |
| KILROY CONOR | General Counsel | Stock Award(Grant) | Apr 1, 2024 | 96,000 |
